- Home
- RIGL vs TITN Comparison
RIGL vs TITN Comparison
Compare RIGL & TITN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RIGL
- TITN
- Stock Information
- Founded
- RIGL 1996
- TITN 1980
- Country
- RIGL United States
- TITN United States
- Employees
- RIGL N/A
- TITN N/A
- Industry
- RIGL Biotechnology: Pharmaceutical Preparations
- TITN Other Specialty Stores
- Sector
- RIGL Health Care
- TITN Consumer Discretionary
- Exchange
- RIGL Nasdaq
- TITN Nasdaq
- Market Cap
- RIGL 298.0M
- TITN 341.6M
- IPO Year
- RIGL 2000
- TITN 2007
- Fundamental
- Price
- RIGL $17.28
- TITN $15.99
- Analyst Decision
- RIGL Buy
- TITN Buy
- Analyst Count
- RIGL 5
- TITN 5
- Target Price
- RIGL $36.80
- TITN $19.00
- AVG Volume (30 Days)
- RIGL 222.1K
- TITN 315.7K
- Earning Date
- RIGL 05-06-2025
- TITN 05-22-2025
- Dividend Yield
- RIGL N/A
- TITN N/A
- EPS Growth
- RIGL N/A
- TITN N/A
- EPS
- RIGL 0.99
- TITN N/A
- Revenue
- RIGL $179,278,000.00
- TITN $2,702,122,000.00
- Revenue This Year
- RIGL $12.53
- TITN N/A
- Revenue Next Year
- RIGL $15.68
- TITN $3.22
- P/E Ratio
- RIGL $17.36
- TITN N/A
- Revenue Growth
- RIGL 54.71
- TITN N/A
- 52 Week Low
- RIGL $7.48
- TITN $12.30
- 52 Week High
- RIGL $29.82
- TITN $24.28
- Technical
- Relative Strength Index (RSI)
- RIGL 44.84
- TITN 49.36
- Support Level
- RIGL $16.05
- TITN $15.41
- Resistance Level
- RIGL $17.52
- TITN $16.44
- Average True Range (ATR)
- RIGL 1.26
- TITN 1.10
- MACD
- RIGL 0.10
- TITN 0.04
- Stochastic Oscillator
- RIGL 63.57
- TITN 68.60
About RIGL Rigel Pharmaceuticals Inc.
Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's primary drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsibility for developing and marketing the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes TAVALISSE (fostamatinib disodium hexahydrate) tablets, the only oral spleen tyrosine kinase (SYK) inhibitor, Fostamatinib, R289, R552, R835, DS-3032, THF-beta Inhibitors, and AZD0449- Inhaled JAK Inhibitor.
About TITN Titan Machinery Inc.
Titan Machinery Inc owns and operates a network of full-service agricultural and construction equipment stores. The company sells and repairs agricultural equipment, including machinery and attachments for large-scale farming and home and gardening purposes, as well as construction equipment. It operates through the following segments: The Agriculture segment sells, services, and rents machinery and related parts and attachments, for uses ranging from large-scale farming to home and garden use, The construction segment sells, services, and rents machinery, and related parts and attachments, for uses ranging from heavy construction to light industrial machinery use, and the Europe and Australia segments.